S-63845

N/A

Report date: 2024/02/04 17:58:03
NME

Base Information

Drug NameS-63845
Drug Alias NameS63845S-63845
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsMultiple MyelomaLymphomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVernalis (R&D) LtdLes Laboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesVernalis (R&D) LtdLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphomaLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A